Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Routine preoperative coagulation screening may identify bleeding risk in cardiac surgery; leaves open corticosteroid benefit for subclinical thrombocytopathy.
THE DEVELOPMENT of a hemorrhagic diathesis following an open-heart operation is a serious complication.1Hemorrhagic disease may develop as a function of: (1) abnormalities directly related to extracorporeal circulation such as thrombocytopenia, defibrination, or fibrinolysis,2(2) depressed coagulation factors associated with hepatic decompensation, (3) occult thrombocytopenia occurring in the setting of congestive splenomegaly or drug purpura,3and (4) subclinical qualitative defects of platelet function. Combinations of these abnormalities may also occur. In order to decrease the possibility of hemorrhagic complications following openheart procedures, a comprehensive coagulation study has been performed upon all adult patients at The New York Hospital-Cornell Medical Center who were candidates for open-heart surgery over the past 3½ years. Included in the comprehensive coagulation study have been the following determinations: clotting time (Lee-White), bleeding time (Duke), tourniquet test (Rumpel-Leede), clot retraction (Qualitative), platelet estimate (blood smear), platelet count (Phase), fibrinogen (Fowell), fibrinolysis (Euglobin), prothrombin
No takes yet. Share an insight, caveat, or question.
George R. Holswade (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: